
• Broad spectrum of antimicrobial activity in solution
• Does not confer antibiotic resistance
• Reduces odor
• Assists in removing biofilm
• Used for a wide variety of acute and chronic wounds
Microcyn® Negative Pressure Wound Therapy Solution is indicated for the management of stage 1-4 pressure ulcers, partial- and full-thickness wounds, diabetic foot ulcers, post-surgical wounds, first- and second-degree burns and grafted and donor sites.
Electrolyzed water, sodium chloride, sodium hypochloride and hypochlorous acid
Antimicrobial | |
Antimicrobial broad-spectrum | |
Non-cytotoxic | ● |
Non-irritating | ● |
Packaging not made w/ natural rubber latex | ● |
Preserved product | ● |
Spikable bottle | ● |
Educational Material Available | ● |
Free Samples/Trials Available | ● |
Published Clinical Article Available |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Pressure Ulcers
Surgical Wounds
Venous Ulcers
Non-irritating
Non-sensitizing
Non-cytotoxic
Sonoma Pharmaceuticals is a commercial health care company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which reduces need for antibiotics while reducing infections and accelerating healing.